30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Healthcare Equipment & Supplies

Avanos Medical Inc (AVNS)

Track

The most recent insider trading activity occurred on November 18, 2025, with significant sell transactions reported by Holbrook Kerr, SVP, Chief Commercial Officer. Prior to this, Gary Blackford made substantial buy transactions on August 13, 2025. Earlier in 2024, Michael Greiner, SVP - Chief Financial Officer, also engaged in multiple sell transactions.
Stock chart
Ticker: AVNS Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Holbrook Kerr
SVP, Chief Commercial Officer
5 sales — total 330,028 USD
Sale 18 Nov 2025
Value US$4,442,466.25 | Price 470.14 | Shares 48,474
Sale 18 Nov 2025
Value US$1,823,021.54 | Price 170.55 | Shares 44,938
Sale 18 Nov 2025
Value US$1,100.50 | Price 11.01 | Shares 100
Sale 18 Nov 2025
Value US$152,174.00 | Price 11.00 | Shares 13,834
Proposed sale 18 Nov 2025
Value US$165,014.21 | Price 11.00 | Shares 15,000
Buy 13 Aug 2025
Value US$4,711,583.72 | Price 27.38 | Shares 95,928
Buy 13 Aug 2025
Value US$2,564,389.46 | Price 386.25 | Shares 1,350
Sale 6 Mar 2025
Value US$106,778.00 | Price 15.25 | Shares 7,000
Proposed sale 6 Mar 2025
Value US$106,780.10 | Price 15.25 | Shares 7,000
Sale 14 Mar 2024
Value US$2,107.60 | Price 19.16 | Shares 110
Sale 14 Mar 2024
Value US$15,473.20 | Price 19.15 | Shares 808
Sale 14 Mar 2024
Value US$6,450.18 | Price 19.14 | Shares 337
Sale 14 Mar 2024
Value US$42,679.03 | Price 19.13 | Shares 2,231
Sale 14 Mar 2024
Value US$13,651.68 | Price 19.12 | Shares 714
Sale 14 Mar 2024
Value US$72,618.00 | Price 19.11 | Shares 3,800
Proposed sale 14 Mar 2024
Value US$152,979.69 | Price 19.12 | Shares 8,000
Buy 11 Mar 2024
Value US$9,925.00 | Price 19.85 | Shares 500
Buy 8 May 2020
Value US$142,500.00 | Price 28.50 | Shares 5,000
Buy 8 May 2020
Value US$145,000.00 | Price 29.00 | Shares 5,000
Buy 30 May 2019
Value US$139,825.00 | Price 39.95 | Shares 3,500
Buy 28 Nov 2018
Value US$151,725.00 | Price 43.35 | Shares 3,500
Buy 27 Nov 2018
Value US$87,470.00 | Price 43.74 | Shares 2,000
Buy 19 Nov 2018
Value US$47,480.00 | Price 47.48 | Shares 1,000
Buy 4 Sep 2015
Value US$310,600.00 | Price 31.06 | Shares 10,000
Buy 1 Sep 2015
Value US$30,000.00 | Price 30.00 | Shares 1,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-11-19 2025-11-18 S Sale
2.0
Holbrook Kerr

SVP, Chief Commercial Officer

Officer
48,474 -42.4%
470.14
US$4,442,466 		48,474 -42.4% 470.14 US$4,442,466
2025-11-19 2025-11-18 S Sale
2.0
Holbrook Kerr

SVP, Chief Commercial Officer

Officer
44,938 +27.1%
170.55
US$1,823,022 		44,938 +27.1% 170.55 US$1,823,022
2025-11-19 2025-11-18 S Sale
2.0
Holbrook Kerr

SVP, Chief Commercial Officer

Officer
49,308 -8.0%
266.31
US$4,991,184 		49,308 -8.0% 266.31 US$4,991,184
2025-11-19 2025-11-18 S Sale
2.0
Holbrook Kerr

SVP, Chief Commercial Officer

Officer
13,834 -14.0%
11.00
US$152,174 		13,834 -14.0% 11.00 US$152,174
2025-11-18 2025-11-18 PrS Proposed sale
2.0
Holbrook Kerr

Former Officer

Officer
15,000
11.00
US$165,014 		15,000 11.00 US$165,014
2025-08-15 2025-08-13 B Purchase
3.8
BLACKFORD GARY
Non-Executive Director
40,000 +inf%
11.00
US$439,800 		40,000 +inf% 11.00 US$439,800
2025-08-15 2025-08-13 B Purchase
3.8
BLACKFORD GARY
Non-Executive Director
20,000 +27.9%
10.98
US$219,500 		20,000 +27.9% 10.98 US$219,500
2025-03-10 2025-03-06 S Sale
2.0
Holbrook Kerr

SVP, Chief Commercial Officer

Officer
7,000 -7.9%
15.25
US$106,778 		7,000 -7.9% 15.25 US$106,778
2025-03-06 2025-03-06 PrS Proposed sale
2.0
Holbrook Kerr

Officer

Officer
7,000
15.25
US$106,780 		7,000 15.25 US$106,780
2024-03-15 2024-03-14 S Sale
2.6
Greiner Michael

SVP - Chief Financial Officer

Officer
110 -0.1%
19.16
US$2,108 		110 -0.1% 19.16 US$2,108
2024-03-15 2024-03-14 S Sale
2.6
Greiner Michael

SVP - Chief Financial Officer

Officer
808 -0.5%
19.15
US$15,473 		808 -0.5% 19.15 US$15,473
2024-03-15 2024-03-14 S Sale
2.6
Greiner Michael

SVP - Chief Financial Officer

Officer
337 -0.2%
19.14
US$6,450 		337 -0.2% 19.14 US$6,450
2024-03-15 2024-03-14 S Sale
2.6
Greiner Michael

SVP - Chief Financial Officer

Officer
2,231 -1.4%
19.13
US$42,679 		2,231 -1.4% 19.13 US$42,679
2024-03-15 2024-03-14 S Sale
2.6
Greiner Michael

SVP - Chief Financial Officer

Officer
714 -0.5%
19.12
US$13,652 		714 -0.5% 19.12 US$13,652
2024-03-15 2024-03-14 S Sale
2.6
Greiner Michael

SVP - Chief Financial Officer

Officer
3,800 -2.4%
19.11
US$72,618 		3,800 -2.4% 19.11 US$72,618
2024-03-14 2024-03-14 PrS Proposed sale
2.6
Greiner Michael

Officer

Officer
8,000
19.12
US$152,980 		8,000 19.12 US$152,980
2024-03-11 2024-03-11 B Purchase
1.1
Shimer Julie Ann
Non-Executive Director
500 +1.0%
19.85
US$9,925 		500 +1.0% 19.85 US$9,925
2020-05-11 2020-05-08 B Purchase
3.8
BLACKFORD GARY
Non-Executive Director
5,000 +16.8%
28.50
US$142,500 		5,000 +16.8% 28.50 US$142,500
2020-05-11 2020-05-08 B Purchase
3.8
BLACKFORD GARY
Non-Executive Director
5,000 +20.1%
29.00
US$145,000 		5,000 +20.1% 29.00 US$145,000
2019-06-03 2019-05-30 B Purchase
1.6
Woody Joseph Fralin

Chief Executive Officer

Executive Director
3,500 +14.0%
39.95
US$139,825 		3,500 +14.0% 39.95 US$139,825
2018-11-29 2018-11-28 B Purchase Woody Joseph Fralin

Chief Executive Officer

Executive Director
3,500 +16.2%
43.35
US$151,725 		3,500 +16.2% 43.35 US$151,725
2018-11-28 2018-11-27 B Purchase Voskuil Steven E

SVP, Chief Financial Officer

Officer
2,000 +9.9%
43.74
US$87,470 		2,000 +9.9% 43.74 US$87,470
2018-11-20 2018-11-19 B Purchase Wesley John W

SVP, General Counsel

Officer
1,000 +15.4%
47.48
US$47,480 		1,000 +15.4% 47.48 US$47,480
2015-09-08 2015-09-04 B Purchase ABERNATHY ROBERT E

Chairman and CEO

Executive Director
10,000 +14.3%
31.06
US$310,600 		10,000 +14.3% 31.06 US$310,600
2015-09-02 2015-09-01 B Purchase Voskuil Steven E

SVP, Chief Financial Officer

Officer
1,000 +3.6%
30.00
US$30,000 		1,000 +3.6% 30.00 US$30,000
Explore more

More insider trading research around Avanos Medical Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America